FDA Urges Hospitals to Check Mattresses
|
By HospiMedica International staff writers Posted on 16 May 2013 |
The US Food and Drug Administration (FDA, Silver Spring, MD, USA) urge healthcare professionals to replace worn medical bed mattress covers to prevent the spread of contamination.
The warning follows 458 reports submitted to the FDA of medical bed mattress covers failing to prevent blood and body fluid ingress between January 2011 and January 2013. Fluid ingress may occur if mattress covers become worn or damaged from small holes or rips in the fabric or from incorrect cleaning, allowing effusions from one patient to penetrate the cover and leak out later, when another patient is placed on the same bed. Damaged covers can also lead to the mattress itself retaining seeping fluids, and the zipper on the mattress cover may also allow fluid to penetrate the mattress.
The FDA therefore recommend that healthcare professionals regularly inspect the mattress covers for visible signs of damage, removing them and inspecting their inside surface (as well as the mattress itself), for any visible signs of damage or wear such as cuts, tears, cracks, pinholes, snags or stains. Once the mattress cover is removed, the mattress should also be inspected for wet spots, staining, or signs of damage or wear on all sides, including the bottom of the mattress. Any medical bed mattress and/or cover with visible signs of damage or wear should be replaced immediately.
“Inspection may prove challenging because most mattress covers are a dark color,” cautioned the FDA. “Healthcare professionals should also create an inspection plan for all mattress covers used in the facility, and any damaged or leaking mattress covers should be replaced immediately.”
Medical bed mattress covers protect mattresses by keeping blood and body fluids from getting into the core of the mattress through water-resistance, waterproofing, or water repelling. These effects may be diluted over time and may vary from mattress cover to mattress cover. Healthcare staff may be largely unaware of the hazards posed by damaged protective coverings on medical beds and risks associated with them, including widespread contamination during infection outbreaks.
Related Links:
US Food and Drug Administration
The warning follows 458 reports submitted to the FDA of medical bed mattress covers failing to prevent blood and body fluid ingress between January 2011 and January 2013. Fluid ingress may occur if mattress covers become worn or damaged from small holes or rips in the fabric or from incorrect cleaning, allowing effusions from one patient to penetrate the cover and leak out later, when another patient is placed on the same bed. Damaged covers can also lead to the mattress itself retaining seeping fluids, and the zipper on the mattress cover may also allow fluid to penetrate the mattress.
The FDA therefore recommend that healthcare professionals regularly inspect the mattress covers for visible signs of damage, removing them and inspecting their inside surface (as well as the mattress itself), for any visible signs of damage or wear such as cuts, tears, cracks, pinholes, snags or stains. Once the mattress cover is removed, the mattress should also be inspected for wet spots, staining, or signs of damage or wear on all sides, including the bottom of the mattress. Any medical bed mattress and/or cover with visible signs of damage or wear should be replaced immediately.
“Inspection may prove challenging because most mattress covers are a dark color,” cautioned the FDA. “Healthcare professionals should also create an inspection plan for all mattress covers used in the facility, and any damaged or leaking mattress covers should be replaced immediately.”
Medical bed mattress covers protect mattresses by keeping blood and body fluids from getting into the core of the mattress through water-resistance, waterproofing, or water repelling. These effects may be diluted over time and may vary from mattress cover to mattress cover. Healthcare staff may be largely unaware of the hazards posed by damaged protective coverings on medical beds and risks associated with them, including widespread contamination during infection outbreaks.
Related Links:
US Food and Drug Administration
Latest Patient Care News
- Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
- Expert Review Outlines Diagnosis and Treatment of Recurrent Catheter Infections
- Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging
- AI Platform Personalizes Support Between Visits for Cancer Survivors
- At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
- EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
- Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
- Weighted Blankets Reduce Anxiety in Hospitalized Adults
- Multicenter Study Quantifies Delays in Care for Emergency Department Boarders
- Real-Time Radiation Monitor Supports Safer Fluoroscopy-Guided Procedures
- FDA-Cleared Finger Cuff Device Enables Home Blood Pressure Monitoring
- AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
- Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
- Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
- VR Training Tool Combats Contamination of Portable Medical Equipment
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Channels
Artificial Intelligence
view channel
AI Tool Improves Hospital Discharge Summaries to Support Follow-Up Care
Discharge summaries guide care after hospitalization but can be difficult to prepare after long or complex stays. Clinicians must condense treatment, medications, follow-up, and unresolved issues into... Read more
AI Tool Predicts Hypertensive Crisis Up to 72 Hours Ahead
A hypertensive crisis is a rapid and severe rise in blood pressure above 180/120 mm Hg accompanied by acute end-organ damage. It can lead to stroke, heart attack, kidney injury, aortic dissection, or pulmonary... Read moreSurgical Techniques
view channel
Dual-Technique Approach Improves Stent Expansion in Calcified Coronary Lesions
Calcified coronary nodules are hard, irregular calcium deposits that protrude into coronary arteries and can complicate percutaneous coronary intervention by preventing full stent expansion.... Read more
FDA Approves First Transcatheter Device for Paravalvular Leak Closure
Paravalvular leak is a backflow of blood around a surgical heart valve that can follow valve replacement, causing heart failure symptoms or hemolysis. These leaks occur in 7%–17% of mitral valve replacements... Read morePatient Care
view channel
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read more
Expert Review Outlines Diagnosis and Treatment of Recurrent Catheter Infections
Patients who rely on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition, and other essential therapies remain at risk of catheter-related bloodstream infections.... Read moreMedical Imaging
view channel
Targeted ImmunoPET Scan Detects Multiple Myeloma Missed by Standard PET/CT
Multiple myeloma is a blood cancer that develops in the bone marrow and can affect multiple sites throughout the body. Standard imaging and blood tests may miss areas of active disease, potentially complicating... Read more
Researchers Develop AI Tool to Reconstruct Missing Brain Connectivity Data
Diffusion MRI helps map nerve fiber pathways in the brain, but some scans lose signal in regions that are important for understanding connectivity. These gaps can affect areas such as the brainstem and... Read more
Cardiac MRI AI Tool Improves Mortality Risk Prediction
Ejection fraction is a key measure of how effectively the heart pumps blood and is widely used to guide treatment decisions in patients with known or suspected heart disease. These measurements can influence... Read more
Imaging Biomarker Links Breast Tumor Heterogeneity to Targeted Therapy Response
Breast cancer patients can respond differently to targeted therapy, even when their tumors appear similar on conventional imaging. This variability can expose some patients to treatments that provide limited... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read morePoint of Care
view channel
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read moreBusiness
view channel
Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal
Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Stryker Enters Soft-Tissue Robotics Through Strategic Alliance With CMR Surgical
Stryker (Portage, MI, USA) and CMR Surgical (Cambridge, UK) have announced a strategic alliance centered on the Versius Surgical Robotic portfolio. The agreement includes an approximately USD 400 million... Read more







